RTI-5152-12
Chemical compound
Overview[edit | edit source]
RTI-5152-12 is a chemical compound that belongs to the class of phenyltropanes, which are known for their stimulant properties. This compound is a derivative of the tropane alkaloid structure and is primarily studied for its potential effects on the central nervous system.
Chemical Structure[edit | edit source]
RTI-5152-12 is characterized by its complex chemical structure, which includes a tropane ring system. The compound is a derivative of the phenyltropane class, which is known for its structural similarity to cocaine. The presence of specific functional groups in RTI-5152-12 contributes to its unique pharmacological profile.
Pharmacology[edit | edit source]
RTI-5152-12 acts primarily as a dopamine reuptake inhibitor, which means it blocks the reabsorption of dopamine into neurons, leading to increased levels of dopamine in the synaptic cleft. This action is similar to that of other stimulant drugs, which can enhance mood, increase alertness, and improve concentration.
The compound's effects on the dopaminergic system make it a subject of interest in the study of neurotransmitter regulation and potential therapeutic applications for disorders such as attention deficit hyperactivity disorder (ADHD) and narcolepsy.
Potential Applications[edit | edit source]
While RTI-5152-12 is primarily a research chemical, its properties as a dopamine reuptake inhibitor suggest potential applications in the treatment of neurological and psychiatric disorders. However, further research is necessary to fully understand its efficacy and safety profile.
Safety and Legal Status[edit | edit source]
As a research chemical, RTI-5152-12 is not approved for medical use in humans. Its legal status may vary by country, and it is typically regulated under laws pertaining to controlled substances. Researchers must adhere to strict guidelines when handling and studying this compound.
Related Compounds[edit | edit source]
RTI-5152-12 is part of a broader class of phenyltropanes, which includes other compounds such as RTI-55 and RTI-113. These compounds share similar mechanisms of action but differ in their potency and selectivity for various neurotransmitter systems.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
